Arkolith/Insider Trading/SGP/Form 4

RA Capital Healthcare Fund LP

Director, 10% OwnerSpyGlass Pharma, Inc. (SGP) · full profile →Form 4 · filed Feb 11, 2026
Net Buying
Open-Market Buys
$59.0M
Open-Market Sells
$0
Net Open-Market Flow
$59.0M
Transactions
10
4 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Buy(P)248K$16.00$4.0M2.1M
Feb 9, 2026Buy(P)3.4M$16.00$55.1M6.0M
Feb 9, 2026Conversion(C)1.8M——1.8M
Feb 9, 2026Conversion(C)2.5M——2.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)767K——0
Feb 9, 2026Conversion(C)272K——0
Feb 9, 2026Conversion(C)1.2M——0
Feb 9, 2026Conversion(C)767K——0
Feb 9, 2026Conversion(C)1.2M——0
Feb 9, 2026Conversion(C)223K——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000135) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML